Capecitabine and paclitaxel combination chemotherapy for inoperable or recurrent breast cancer: a phase I dose-finding study by the Kinki Breast Cancer Study Group

被引：0
|
作者：
Norikazu Masuda
Tetsuya Taguchi
Takahiro Nakayama
Eiichi Shiba
Masahiro Watatani
Junichi Kurebayashi
Yuichi Takatsuka
Junichi Sakamoto
Shinzaburo Noguchi
机构：
[1] Breast Oncology Group,Department of Surgery
[2] Osaka National Hospital,Graduate School of Medicine, Department of Breast and Endocrine Surgery
[3] Osaka University,Department of Surgery
[4] Sakai Municipal Hospital,Department of Breast and Endocrine Surgery
[5] Osaka Koseinenkin Hospital (Osaka Breast Clinic),Department of Surgery
[6] Kinki University Hospital,Department of Breast and Thyroid Surgery
[7] Kawasaki Medical School,Department of Surgery
[8] Kansai Rosai Hospital,Graduate School of Medicine, Social Life Science, Young Leaders’ Program
[9] Nagoya University,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2008年 / 61卷
关键词：
Metastatic breast cancer; Capecitabine; Weekly; Paclitaxel; Phase I;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：989 / 995
页数：6
相关论文
共 50 条
  • [1] Capecitabine and paclitaxel combination chemotherapy for inoperable or recurrent breast cancer: a phase I dose-finding study by the Kinki Breast Cancer Study Group
    Masuda, Norikazu
    Taguchi, Tetsuya
    Nakayama, Takahiro
    Shiba, Eiichi
    Watatani, Masahiro
    Kurebayashi, Junichi
    Takatsuka, Yuichi
    Sakamoto, Junichi
    Noguchi, Shinzaburo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 61 (06) : 989 - 995
  • [2] Capecitabine with weekly paclitaxel for advanced breast cancer: A phase I dose-finding trial
    Uhlmann, C
    Ballabeni, P
    Rijken, N
    Brauchli, P
    Mingrone, W
    Rauch, D
    Pestalozzi, BC
    Rochlitz, C
    Aebi, S
    ONCOLOGY, 2004, 67 (02) : 117 - 122
  • [3] Dose-finding phase I and pharmacokinetic study of capecitabine (xeloda) in combination with epirubicin and cyclophosphamide (CEX) in patients with inoperable or metastatic breast cancer
    Saji, Shigehira
    Toi, Masakazu
    Morita, Satoshi
    Iwata, Hiroji
    Ito, Yoshinori
    Ohno, Shinji
    Kobayashi, Tadashi
    Hozumi, Yasuo
    Sakamoto, Junichi
    ONCOLOGY, 2007, 72 (5-6) : 330 - 337
  • [4] Phase I, dose-finding study of capecitabine in combination with docetaxel and epirubicin as first-line chemotherapy for advanced breast cancer
    Venturini, M
    Del Mastro, L
    Garrone, O
    Angiolini, C
    Merlano, M
    Bergaglio, M
    Tolino, G
    Lambiase, A
    Baldini, A
    Canavese, G
    Rosso, R
    ANNALS OF ONCOLOGY, 2002, 13 (04) : 546 - 552
  • [5] A dose-finding study of epirubicin in combination with paclitaxel in the treatment of advanced breast cancer
    Conte, PF
    Michelotti, A
    Baldini, E
    Salvadori, B
    Gennari, A
    DaPrato, M
    Tibaldi, C
    Salzano, E
    Gentile, A
    SEMINARS IN ONCOLOGY, 1996, 23 (05) : 28 - 31
  • [6] Dose-finding study of capecitabine in combination with weekly paclitaxel for patients with anthracycline-pretreated metastatic breast cancer
    Susnjar, S.
    Bosnjak, S.
    Radulovic, S.
    Stevanovic, J.
    Gajic-Dobrosavljevic, M.
    Kreacic, M.
    JOURNAL OF BUON, 2007, 12 (02): : 189 - 196
  • [7] Dose-finding study of paclitaxel and cyclophosphamide in advanced breast cancer
    Pagani, O
    Sessa, C
    Martinelli, G
    Cerny, T
    deJong, J
    Goldhirsch, A
    Zimatore, M
    Cavalli, F
    ANNALS OF ONCOLOGY, 1997, 8 (07) : 655 - 661
  • [8] A phase I dose-finding study of capecitabine in combination with epirubicin and docetaxel as first-line chemotherapy in advanced breast cancer patients.
    Angiolini, C
    Venturini, M
    Del Mastre, L
    Bergaglio, M
    Garrone, O
    Merlano, M
    Tolino, G
    Lambiase, A
    Bighin, C
    Stevani, I
    Catzeddu, T
    Bertelli, G
    Rosso, R
    ANNALS OF ONCOLOGY, 2000, 11 : 36 - 36
  • [9] Dose-finding study of paclitaxel and cyclophosphamide in women with advanced breast cancer
    Sessa, C
    Pagani, O
    Martinelli, G
    Cerny, T
    deJong, J
    Goldhirsch, A
    Zimatore, M
    Cavalli, F
    SEMINARS IN ONCOLOGY, 1997, 24 (05) : 52 - 57
  • [10] Correction to: Phase I dose-finding study of eribulin and capecitabine for metastatic breast cancer: JBCRG-18 cape study
    Masaya Hattori
    Hiroshi Ishiguro
    Norikazu Masuda
    Akiyo Yoshimura
    Shoichiro Ohtani
    Hiroyuki Yasojima
    Satoshi Morita
    Shinji Ohno
    Hiroji Iwata
    Breast Cancer, 2018, 25 : 126 - 126
12345